Eskay Speciality Chemicals has grown 35% annually over two years

BT-YES Bank Best SME Survey
ESKAY SPECIALITY CHEMICALS
The Rs 600-crore SK Group, of which Eskay Speciality Chemicals is a part, has never roped in any investors from outside the founding Shah family.
This is because whenever one part of the business requires money other units chip in, says Ketan Shah, CEO of Eskay Speciality and one of seven cousins who run the group. Eskay Speciality was set up in 2006 and makes niche chemicals that are used in the making of ointments and medicines.
The company gets nearly 80 per cent of its revenue from exports, mainly to the US and Europe. Shah says the company has about 25 customers, including the likes of Sanofi, Procter & Gamble, and Novartis.
Clients vouch for the company. Pradeep Thakur, who heads the India sourcing arm of US-based pharmaceuticals and chemicals company Aceto, has been an Eskay customer for more than decade. He says the company is profit-oriented but doesn't try to exploit customers who are bound by tough regulatory concerns. Eskay also looks after the interests of its customers, he says, adding: "We have never lost business because of [Eskay's] greed."
FULL COVERAGE: India's Best SMEs